1-8 of 8
Barbara Castagnari, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine and Lenalidomide in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study and Impact of Cytogenetic Scores and Mutational Status on Long-Lasting Responses

Carlo Finelli, Sarah Parisi, MDPhD, Matilde Y Follo, PhD, Cristina Clissa, MD, Miriam Fogli, PhD, Sara Mongiorgi, PhD, Costanza Bosi, MD, Isabella Capodanno, MD, Barbara Castagnari, MD, Anna Candoni, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Giovanna Leonardi, Maurizio Miglino, PhD, Gian Matteo Rigolin, Domenico Russo, MD, Patrizia Tosi, Andrea Pellagatti, Jacqueline Boultwood, Lucio Cocco, MD, Michele Cavo
Journal: Blood
Blood (2020) 136 (Supplement 1): 45.
https://doi.org/10.1182/blood-2020-138371
Published: 2020
Journal Articles

Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study

Carlo Finelli, MD, Cristina Clissa, MD, Matilde Y Follo, PhD, Sarah Parisi, Miriam Fogli, PhD, Sara Mongiorgi, PhD, Isabella Capodanno, Costanza Bosi, MD, Barbara Castagnari, MD, Anna Candoni, MD, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Marco Gobbi, MD, Giovanna Leonardi, Gian Matteo Rigolin, Domenico Russo, MD, Patrizia Tosi, MD, Andrea Pellagatti, PhD, Jacqueline Boultwood, PhD, Lucio Cocco, MD, Michele Cavo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4365.
https://doi.org/10.1182/blood-2018-99-117714
Published: 2018
Journal Articles

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Emilio Iannitto, MD, Monica Bellei, MSc, PhD, Andrés J M Ferreri, MD, Luigi Marcheselli, MS, Marina Cesaretti, MD, Corinne Haioun, Salvatrice Mancuso, Krimo Bouabdallah, MD, Remy Gressin, MD, Claudio Tripodo, MD, Alexandra traverse-Glehen, MD PhD, Lucile Baseggio, MD, Simonetta Zupo, Caterina Stelitano, Barbara Castagnari, MD, Caterina Patti, MD, Francesco Merli, Anna Marina Liberati, MD, Michele Merli, Guido Gini, Maria Giuseppina Cabras, Jehan Dupuis, MD, Francesca Re, Emanuele Zucca, MD, Massimo Federico, MD, Catherine Thieblemont, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4062.
https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062
Published: 2017
Journal Articles

Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

Carlo Finelli, MD, Cristina Clissa, MD, Matilde Follo, PhD, Marta Stanzani, MD, Sarah Parisi, MD, Sara Mongiorgi, PhD, Marilena Barraco, PhD, Paolo Avanzini, MD, Costanza Bosi, MD, Barbara Castagnari, MD, Anna Candoni, MD, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Marco Gobbi, MD, Giovanna Leonardi, Gian Matteo Rigolin, Domenico Russo, MD, Patrizia Tosi, Giuseppe Visani, MD, Lucio Cocco, MD, PhD, Michele Cavo, MD
Journal: Blood
Blood (2016) 128 (22): 3169.
https://doi.org/10.1182/blood.V128.22.3169.3169
Published: 2016
Journal Articles

Association of Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in High-Risk Myelodysplastic Syndromes. Final Results of a Randomized Phase II Multicenter Study

Carlo Finelli, MD, Cristina Clissa, MD, Matilde Follo, PhD, Marta Stanzani, MD, Sarah Parisi, MD, Sara Mongiorgi, PhD, Paolo Avanzini, MD, Costanza Bosi, MD, Barbara Castagnari, MD, Anna Candoni, MD, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Marco Gobbi, MD, Giovanna Leonardi, Gian Matteo Rigolin, Domenico Russo, Patrizia Tosi, Giuseppe Visani, MD, Lucio Cocco, MD, PhD, Michele Cavo
Journal: Blood
Blood (2015) 126 (23): 2871.
https://doi.org/10.1182/blood.V126.23.2871.2871
Published: 2015
Journal Articles

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Alessandro Isidori, MD PhD, Stefano Guidi, Potito Rosario Scalzulli, MD, Attilio Olivieri, MD, Emanuele Angelucci, Saveria Capria, MD, Francesca Patriarca, Barbara Castagnari, MD, Francesco Angrilli, MD, Daniele Vallisa, MD, Gerardo Musuraca, Andrea Mengarelli, MD, Piero Galieni, Gaudio Francesco, Patrizia Tosi, Pier Luigi Zinzani, MD PhD, Alberto Bosi, Donatella Baronciani, Nicola Cascavilla, MD, Barbara Guiducci, Cristina Clissa, MD, Elisa Gabucci, Marco Rocchi, Federica Loscocco, PhD, Giuseppe Visani, MD
Journal: Blood
Blood (2015) 126 (23): 1999.
https://doi.org/10.1182/blood.V126.23.1999.1999
Published: 2015
Journal Articles

Addition of Lenalidomide (LEN) to Azacitidine (AZA) (Combined vs Sequential Treatment) in High-Risk Myelodysplastic Syndromes (MDS): A Randomized Phase II Multicenter Study

Carlo Finelli, MD, Cristina Clissa, MD, Matilde Y Follo, PhD, Marta Stanzani, MD PhD, Paolo Avanzini, Costanza Bosi, MD, Barbara Castagnari, MD, Anna Candoni, MD, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Marco Gobbi, MD, Giovanna Leonardi, MD, Gian Matteo Rigolin, MD, Patrizia Tosi, MD, Giuseppe Visani, MD, Lucio Cocco, MD, Michele Cavo, MD, Domenico Russo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4648.
https://doi.org/10.1182/blood.V124.21.4648.4648
Published: 2014
Journal Articles

Long Term Efficacy of Percutaneous Vertebroplasty in Multiple Myeloma (MM) Patients: Experience of the “Gruppo Ematologico Di Romagna” (GER)

Patrizia Tosi, MD, Annalia Molinari, MD, Michele Sintini, MD, Anna Merli, MD, Michela Ceccolini, MD, Manuela Imola, MD, Paolo Savini, MD, Silvana Pasini, MD, Anna M Mianulli, MD, Barbara Castagnari, MD, Pier P Fattori, MD, Giovanni Martinelli, MD, PhD, Alfonso Zaccaria
Journal: Blood
Blood (2011) 118 (21): 5123.
https://doi.org/10.1182/blood.V118.21.5123.5123
Published: 2011